NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 37 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,148,000 | -33.3% | 860,619 | 0.0% | 0.13% | -38.9% |
| Q3 2021 | $6,222,000 | -71.4% | 860,619 | -63.5% | 0.22% | -73.5% |
| Q2 2021 | $21,772,000 | -43.4% | 2,358,804 | -24.5% | 0.81% | -52.3% |
| Q1 2021 | $38,440,000 | -12.7% | 3,122,704 | 0.0% | 1.70% | -28.0% |
| Q4 2020 | $44,030,000 | -5.0% | 3,122,704 | -19.2% | 2.37% | -28.4% |
| Q3 2020 | $46,355,000 | -21.0% | 3,862,931 | +9.2% | 3.30% | -23.8% |
| Q2 2020 | $58,709,000 | +39.7% | 3,536,684 | -4.2% | 4.34% | -1.3% |
| Q1 2020 | $42,029,000 | -12.9% | 3,693,203 | -5.7% | 4.39% | +1.0% |
| Q4 2019 | $48,244,000 | +647.0% | 3,915,880 | +72.8% | 4.35% | +432.8% |
| Q3 2019 | $6,458,000 | – | 2,265,880 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |